Intensive Care Anxiety in SARS-CoV-2 Patients

Derince Training and Research Hospital

Status: Unknown

Conditions: Anxiety

Treatments: Behavioral: Hospital Anxiety Depression Measure

Study type: Observational

Funder types: Other

Identifiers

NCT04715477

derince TRH 2

Details and patient eligibility

About

It should be known by the clinician that COVID-19 patients are prone to anxiety, and these disorders need to be properly diagnosed and addressed to improve prognosis, shorten hospital stay and avoid long-term mental health problems.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Above 18 years old
• COVID PCR +,
• admitted to intensive care,
• conscious, cooperative patients

Exclusion criteria

• Having hearing and speaking problems,
• Can't speak Turkish or English,
• who do not have the cognitive level to understand and answer the questions,
• Communication problems such as dementia and Alzheimer's,
• patients receiving sedation

Trial design

100 participants in 1 patient group

Hospital Anxiety Depression Measure

Description:

Hospital Anxiety Depression Measure

Treatment:

Behavioral: Hospital Anxiety Depression Measure